Theratechnologies EV/EBIT
Was ist das EV/EBIT von Theratechnologies?
EV/EBIT von Theratechnologies Inc. ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Theratechnologies
Was macht Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Unternehmen mit ev/ebit ähnlich Theratechnologies
- DATATRAK International hat EV/EBIT von N/A
- New York Mortgage Trust Inc hat EV/EBIT von N/A
- Surface Oncology Inc hat EV/EBIT von N/A
- Deciphera Pharmaceuticals Inc hat EV/EBIT von N/A
- Nymox Pharmaceutical Corp hat EV/EBIT von N/A
- Walker River Resources hat EV/EBIT von N/A
- Theratechnologies hat EV/EBIT von N/A
- Palred Technologies hat EV/EBIT von N/A
- Eton Pharmaceuticals hat EV/EBIT von N/A
- The Very Good Food hat EV/EBIT von N/A
- Jangada Mines Plc hat EV/EBIT von N/A
- Northern Lion Gold hat EV/EBIT von N/A
- Just Plc hat EV/EBIT von N/A